This inventor holds 1 USPTO granted patent. Top assignee: Les Laboratoires Servier. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Carole Jellimann: Innovator in Pharmaceutical Compounds
Introduction
Carole Jellimann is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of tricyclic compounds. His work is essential for advancing medical treatments and improving patient care.
Latest Patents
Carole Jellimann holds a patent for "Tricyclic compounds, preparation method and pharmaceutical compositions containing same." This invention concerns compounds of formula (I), where A forms a tricyclic system of various specified formulas. The patent outlines that R can represent a hydrogen atom, an alkyl, hydroxy, alkoxy, or oxo group. The invention is particularly useful for preparing medicines, showcasing Jellimann's commitment to enhancing healthcare solutions. He has 1 patent to his name.
Career Highlights
Throughout his career, Carole Jellimann has worked with Les Laboratoires Servier, a prominent pharmaceutical company. His role at the company has allowed him to focus on innovative research and development in the pharmaceutical sector. His contributions have been instrumental in creating effective medicinal compounds.
Collaborations
Carole has collaborated with esteemed colleagues such as Michel Langlois and Monique Mathe-Allainmat. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Carole Jellimann's work in the field of pharmaceutical compounds exemplifies the impact of innovation on healthcare. His patent for tricyclic compounds highlights his dedication to improving medical treatments. Through his career at Les Laboratoires Servier and collaborations with other professionals, Jellimann continues to contribute significantly to the advancement of pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
